(the “Company”) held the Board of Directors’ Meeting No. 6/2017 on December 12, 2017. The meeting unanimously approved significant matters as follows: 1. Approved the reduction of the Company’s
. 2 From the reconsideration of investment in S-TREK, the Board of Directors’ meeting has approved to postpone the investment in S-TREK for the following reasons: 1) Accounting record of S-TREK
and shareholders. 2 From the reconsideration of investment in S-TREK, the Board of Directors’ meeting has approved to postpone the investment in S-TREK for the following reasons: 1) Accounting record of
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
product quality (the company has been awarded ISO 13485, the Quality Management System for Medical Device Industry), which is an important tool in the competition and expansion of the market in the future
name="viewport">` in some cases. @at-root { @-ms-viewport { width: device-width; } } // stylelint-disable selector-list-comma-newline-after // Shim for "new" HTML5 structural elements to display
accordance with the following rules and shall supervise that its own personnel comply with such rules as well: (1) establish a written outsourcing policy having been approved by the intermediary’s board of